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3Voiland School of Chemical Engineering and Bioengineering, Washington State University, Pullman, WashingtonABSTRACT The super-relaxed state of myosin (SRX), in which the myosin ATPase activity is strongly inhibited, has been
observed in a variety of muscle types. It has been proposed that myosin heads in this state are inhibited by binding to the
core of the thick filament in a structure known as the interacting-heads motif. The myosin inhibitor blebbistatin has been shown
in structural studies to stabilize the binding of myosin heads to the thick filament, and here we have utilized measurements of
single ATP turnovers to show that blebbistatin also stabilizes the SRX in both fast and slow skeletal muscle, providing further
support for the proposal that myosin heads in the SRX are also in the interacting-heads motif. We find that the SRX is stabilized
using blebbistatin even in conditions that normally destabilize it, e.g., rigor ADP. Using blebbistatin we show that spin-labeled
nucleotides bound to myosin have an oriented spectrum in the SRX in both slow and fast skeletal muscle. This is to our knowl-
edge the first observation of oriented spin probes on the myosin motor domain in relaxed skeletal muscle fibers. The spectra for
skeletal muscle with blebbistatin are similar to those observed in relaxed tarantula fibers in the absence of blebbistatin, demon-
strating that the structure of the SRX is similar in different muscle types and in the presence and absence of blebbistatin. The
mobility of spin probes attached to nucleotides bound to myosin shows that the conformation of the nucleotide site is closed in
the SRX.INTRODUCTIONThe thick filaments, which form the central part of the sarco-
mere in striated muscle fibers, are composed primarily of
the protein myosin. The tail regions of myosin aggregate
together, along with a number of accessory proteins, to
form the core of the filament. The myosin heads can project
out from the filament in a disordered state, where they
interact with the actin thin filaments to produce force. The
myosin heads can bind to the core of the thick filament in
an ordered helical array, as observed using small-angle
x-ray diffraction and electron microscopy (1–4). Cryo-elec-
tron microscopy has provided images of the structure of the
myosin heads on the surface of the thick filament, with
the greatest resolution in tarantula filaments (5,6). The
two myosin heads of one molecule were shown to interact
with one another in a structural arrangement called the
interacting-heads motif (IHM). A similar structural arrange-
ment had been seen earlier in two-dimensional crystals of a
fragment of myosin from smooth muscle (7). Because the
evolutionary distance between tarantula exoskeletal fibers
and vertebrate smooth muscle cells is so great, this observa-
tion suggested that the IHM is likely widespread among
diverse muscle types (2,4,8). The motif has now been
observed by electron microscopy in a number of inverte-
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0006-3495/14/10/1637/10 $2.00scallop, as well as in thick filaments from vertebrate cardiac
muscle and isolated proteins from vertebrate skeletal muscle
(2,4–7,9–12).
Blebbistatin is a small, recently discovered molecule that
inhibits the ATPase activity of myosin 2 (13). It binds inside
the prominent 50 K cleft that bisects the head region of
myosin (14). It is thought that by preventing the cleft from
closing, blebbistatin stabilizes a conformation of the nucle-
otide pocket, inhibiting the rapid hydrolysis and release
of nucleotides. It inhibits the ATPase activity of skeletal
myosin by 10- to 20-fold (15,16). Blebbistatin also stabi-
lizes the binding of myosin heads to the core of the thick
filament in the helical array (17,18). X-ray diffraction of
vertebrate fast skeletal muscle fibers shows that blebbistatin
induces a roughly three times greater affinity of myosin
heads for the core of the thick filament (17). Blebbistatin
has also been used to stabilize this helical array for electron
microscopy of cardiac filaments (11) and to stabilize the
IHM in purified preparations of fast skeletal muscle myosin
(2). It is hypothesized that by stabilizing a conformation of
the myosin head with a closed nucleotide pocket, blebbista-
tin favors the IHM (18,19).
Our own lab has been studying single fluorescent nucleo-
tide turnovers by myosin in a variety of muscle types. This
has led to the identification of a highly inhibited state of
myosin in which ATP turnover is ~10 times slower than
the activity observed for purified myosin in a test tube
(20–22). We have called this new state the super-relaxedhttp://dx.doi.org/10.1016/j.bpj.2014.07.075
1638 Wilson et al.state (SRX). A correlation between structural studies and
measurements of ATP turnover have suggested that the
inhibition of myosin seen in the SRX is due to the binding
of myosin heads to the core of the thick filament in the
IHM (22). Supporting this hypothesis, previous observations
showed that myosin in the IHM has an extremely slow ATP
turnover rate in scallop filaments and also for purified
smooth muscle myosin in the absence of a thick filament
(23,24). In both of these systems, the primary control of
muscle function is exerted by myosin modification, either
phosphorylation or calcium binding (23–25). Our observa-
tions suggest that a similar but less extreme inhibition of
myosin also occurs in vertebrate skeletal and cardiac mus-
cles when myosin heads are in conditions that favor the
IHM. A second relaxed state also exists, in which myosin
heads are detached from the core of the thick filaments
and are disordered and capable of binding weakly to actin.
Disordered myosin heads in relaxed fibers have been
demonstrated by spectroscopic probes and by loss of
myosin-based layer lines in the x-ray diffraction patterns
(26–28). We term this state the disordered relaxed state
(DRX). In tarantula filaments, there is evidence for a third
state with an intermediate lifetime, which may correspond
to a structural state in which one of the two myosin heads
is immobilized but its partner head has rotational flexibility
(25,29). Because of the large difference in myosin ATPase
activity between the SRX and the DRX, the relative popula-
tions of these states play a major role in whole-body
metabolism.
To explore further the properties of the SRX, correlations
with myosin structure, and ATPase, we extended our studies
by observing the effect of blebbistatin on myosin turnover
rates. We found that blebbistatin inhibited nucleotide turn-
over in both fast and slow skeletal muscle with a lifetime in-
crease to 1 h or more. This stability of the SRX allowed us to
observe structural features using electron paramagnetic
resonance (EPR) spectroscopy of spin-labeled nucleotides.
In contrast to previous studies, in which only disordered
probes on the motor domain could be observed (30–32),
we were able to identify oriented spin probes attached to
nucleotides in the relaxation state. In addition, we were
able to monitor the conformation of the nucleotide pocket
in the SRX.MATERIALS AND METHODS
Chemicals and solutions
Chemicals were purchased from Sigma (St. Louis, MO), except blebbistatin
((5)-1-Phenyl-1,2,3,4-tetrahydro-4-hydroxypyrrolo(2.3-b)-7-methylqui-
nolin-4-one), which was obtained from Toronto Research Chemicals (North
York, Ontario, Canada). Blebbistatin was dissolved in dimethylformamide
and stored at20C in the dark. It was diluted with buffer before use. Expo-
sure to light was minimized, as ultraviolet light can lead to photooxidation
of blebbistatin. Rigor buffer consisted of 120 mM Kacetate, 5 mM MgCl2,
5 mM EGTA, 5 mM Kphosphate, 50 mM 3-(N-morpholino)propanesul-Biophysical Journal 107(7) 1637–1646fonic acid, pH 6.8. Relaxing buffers were obtained by addition of 4 mM
ATP, 250 mM mantATP, or 100 mM spin-labeled ATP EPR probe (SLATP)
to the rigor buffer.Preparation of muscle fibers
Rabbits were sacrificed according to protocols approved by the Institutional
Animal Care and Use Committee. Muscle skeletal fibers were dissected,
permeabilized by immersion in rigor buffer containing 50% glycerol and
stored at 20C, as described in Karatzaferi et al. (33). Fast fibers were
from psoas and slow fibers from soleus or semimembranosus muscles.
Tarantula fibers were prepared as described previously and also stored in
a solution containing 50% glycerol at 20C (25).Measurement of fluorescence
For measurements of fluorescence, fibers were mounted in a simple flow
cell as described previously (22). They were secured at either end with
grease or, for some experiments, by stainless steel pins. They were observed
with a TE2000 microscope (Nikon, Melville, NY), using a DAPI filter set
(no. 89000, Chroma, Bellows Falls, VT). Sarcomere length varied from
2.2 to 2.6 mm. Stewart and co-workers reported no statistically significant
difference in the SRX fractions with sarcomere length (22), and none
were found here in the presence of blebbistatin. The decay of intensity in
this experiment was not due to photobleaching. This is because the fiber
is only exposed to the exciting light for a brief period during data acquisi-
tion, typically 30 ms, and data were acquired at intervals of 20 s. Fluores-
cence decreased by only 12% during constant illumination for 36 s (25),
which is much more than the total exposure of ~11 s during a 2-h epifluor-
escence microscopy run.EPR spectroscopy
EPR measurements were performed with an EMX EPR spectrometer
(Bruker, Billerica, MA). First-derivative, X-band spectra were recorded in
a high-sensitivity microwave cavity using 50-s, 10-mT-wide magnetic-field
sweeps. The instrument settings were as follows: microwave power, 25
mW; time constant, 164 ms; frequency, 9.83 GHz; and modulation, 0.1
mT at a frequency of 100 kHz. Each spectrum used in data analysis was
an average of 10–50 sweeps from an individual experimental preparation.
Temperature was 24 5 2C and was monitored using a thermistor placed
close to the experimental sample.Labeling fibers for EPR experiments
Small bundles of 8–10 fibers 10 mm long were dissected and cleaned
from fat and connective tissues. The fibers were washed for 15 min
with rigor buffer, then incubated for 15 min to 2 h in 40 mM blebbistatin
solution in rigor buffer, to which was added 100 mM of the adenylate
kinase inhibitor P1,P5-diadenosinepentaphosphate (AP5A). The longer in-
cubation times were controls to insure adequate perfusion. No difference
was noted between fiber bundles incubated for 15 min and those incu-
bated for 2 h. Incubations of <15 min were not tried. Bundles were
then labeled with 100 mM 2030-SLATP (34) in rigor buffer with or without
40 mM blebbistatin and AP5A. The EPR-probe moiety is attached to the
20- and 30-hydroxyls as an enantiomer species. 2030-SLATP is hydrolyzed
by myosin, so our observations are from the diphosphate species. For
EPR measurement, the fibers were aligned on the flat cell, covered
with a glass coverslip that was sealed with vacuum grease to prevent
dehydration, and placed in the cavity. EPR spectra of the fibers were ob-
tained with the fiber axis aligned either parallel or perpendicular to the
magnetic field. Random spectra were obtained using minced fibers that
were treated the same way.
Blebbistatin Stabilizes the Super-Relaxed State 1639ATP chase experiments
The amount of nucleotide trapped at the ATP-binding site of myosin in the
presence of blebbistatin was measured using EPR spectroscopy. Rabbit
muscle fibers were labeled with 2030-SLATP in the presence and absence
of blebbistatin, and the EPR spectra were recorded. Two protocols were em-
ployed to measure spectra during the chase with 4 mM ATP plus 100 mM
AP5A. In the first protocol, which was used to obtain parallel and perpen-
dicular spectra of the specifically bound SLADP, the coverslip was removed
from the top of the fibers and the fibers were left on the flat cell. A 100 mL
solution of 4 mMATP in rigor buffer containing blebbistatin and AP5Awas
added to the fibers and the cell was agitated for ~5–10 min. The extra so-
lution was removed and the fibers were then aligned on the flat cell and
covered with the glass slip as described above. The EPR spectra were moni-
tored with time. Spectra of one to five scans were recorded for up to 1 h. The
second protocol was used to measure nucleotide release during the chase. In
this protocol, a small aliquot of concentrated ATP solution was added to the
labeled fibers on the flat cell to produce a final concentration of 4 mM ATP.
The EPR spectra were monitored with time. In this experiment, all nu-
cleotides released remain in the observed volume and contribute to the
spectrum.Labeling myosin and subfragment 1
Rabbit skeletal myosin was prepared as described previously (35), and sub-
fragment 1 was made according to the method of Weeds and Taylor (36).
For trapping spin-labeled nucleotides with blebbistatin, a 60 mM myosin
sample was incubated in rigor buffer containing 120 mM blebbistatin, fol-
lowed by addition of 50 mM of 2030-SLATP. For the ATP competition exper-
iment, 1–2 mL of a concentrated ATP solution was added to the above
labeled myosin sample to generate a final 4 mM ATP concentration. EPR
spectra were recorded at ~2 min intervals for 1 h. Subfragment 1 (100
mM) was labeled with 80 mM 2030-SLATP according to the same procedure
used to label myosin.A BCalculations of the concentration of trapped
nucleotide at the ATP binding site
The EPR spectrum of 2030-SLADP bound at the nucleotide-binding site of
myosin shows two sets of peaks. The height of the high-field free peak was
used to represent the concentration of free probe, whereas the height of the
low-field bound peak was chosen to represent the bound probe. The heights
of the free and bound peaks were measured for each spectrum and were
plotted versus time after the addition of ATP. A plot of the height of the
free probe versus that of the bound probe gave a straight line. The slope pro-
vided a measure of the relative number of spins that were contributing to
each peak, with the free probes having a height per probe that was 25–30
times greater than that of bound probes.FIGURE 1 (A) Fiber fluorescence is shown during the chase phase for a
slow-twitch fiber in the absence (lower trace) and presence (upper trace) of
blebbistatin. The fiber was first incubated in 250 mM mantATP and subse-
quently chased with a solution containing 4 mM ATP. The decay of fluores-
cence was fit by a two-exponential decay function, as described previously
(22). For the experiment with blebbistatin, blebbistatin was included in both
the incubation and chase solutions. (B) The decay of fiber fluorescence dur-
ing the chase phase in the presence of blebbistatin is contrasted for a fast-
(lower trace) and slow-twitch (upper trace) muscle fiber. As can be seen,
the effect of blebbistatin on the rate of release of nucleotides is greater in
the slow-twitch muscle fiber than in the fast-twitch muscle fiber.RESULTS
Measurements of nucleotide turnover in the SRX
using fluorescent nucleotides
Skinned fibers are complex preparations containing a num-
ber of enzymes that rapidly turn over ATP. In addition, there
is a small fraction of myosin heads that are not regulated and
thus have high ATPase activity. These effects have domi-
nated traditional ATPase measurements on relaxed skinned
fibers. To measure the very slow ATP turnover of myosin in
the SRX, it is necessary to measure single nucleotide turn-
overs. We use quantitative epifluorescence microscopy offluorescent mant-nucleotides bound to myosin to observe
the SRX (22). MantATP functions similarly to ATP and
has an enhanced fluorescence when bound to myosin
(37,38).
Single fibers in rigor solution were mounted in a flow
cell, incubated in a relaxing solution containing mantATP
(250 mM), then chased with a relaxing solution containing
4 mM ATP. The fiber fluorescence decayed as the mant-nu-
cleotides were released from myosin, replaced by ATP, and
subsequently diffused out of the fiber. Fig. 1 A shows the
fluorescence signal during the chase phase of an experiment
using a slow muscle fiber (control). The signal decays in
multiple components. The initial rapid decay is compatible
with the presence of rapid ATPases within the bundle
(>0.05 s1), the release of nonspecifically bound nucleo-
tides (presumably fast), and the diffusion of these released
nucleotides out of the fiber in ~10 s (39). The decay of fluo-
rescence intensity is adequately fit to a two-exponential
function, with the rapid decay consisting of 49% of the
initial intensity occurring with a time constant of 17 s and
a slower SRX decay of magnitude 43% with a time constant
of 152 s, similar to that published previously for slow-twitch
fibers (see Table 1) (22). In addition, there is a small compo-
nent (~5%) that does not decay during the experiment in the
absence of blebbistatin but can be quite large in its presence
(see below). Controls showed that photobleaching is insig-
nificant in these experiments (Methods).
To observe the effect of blebbistatin on the SRX, the
slow-twitch fiber was first incubated in a rigor solution
containing 40 mM blebbistatin for 10–20 min to allow bleb-
bistatin to bind to myosin in the fiber. The fiber was next
incubated in mantATP and chased with ATP, all in the
presence of blebbistatin. As shown in Fig. 1 A, blebbistatin
has a dramatic effect on the release of nucleotides inBiophysical Journal 107(7) 1637–1646
TABLE 1 Nucleotide turnover times and populations of
nucleotides with the slow release rate in the absence and
presence of blebbistatin
Sample P2 T2 (s) P2 þ BLEBB T2 þ BLEBB (s)
Fast fibers 0.3 5 0.03 2505 25 (20) 0.355 0.05 36005 500 (5)
Slow fibers 0.3 5 0.04 1505 20 (15) 0.45 0.05 >3600 (6)
Fast myosin — 165 4a — 8005 100 (6)
Slow myosin — 26b — 8205 200 (5)
Values are expressed as the mean5 SE of 5–20 observations, as indicated
by the numbers in parentheses after T2 values. T2, SRX nucleotide turnover
time; P2, slow-release-rate nucleotide population.
aATPase rate in the absence of blebbistatin taken from Myburgh et al. (40).
bSteady-state ATPase rate of relaxed myofibrils taken from the data of
Candau et al. (41).
FIGURE 2 Decay of fiber fluorescence late in the chase phase is shown
as a function of time. A muscle fiber was first incubated in mantATP and
subsequently chased by ATP. The arrow marks the time where the solution
was exchanged for one containing 4 mM ADP. All solutions were in the
presence of blebbistatin. The two upper traces represent experiments per-
formed with a slow-twitch fiber in 40 mM blebbistatin (solid circles) or
in 20 mM blebbistatin (solid diamonds). The lower trace represents the
experiment performed with a fast-twitch fiber in 40 mM blebbistatin
(open squares). As can be seen, there are only modest changes in the rate
of release of fluorescent nucleotides in ADP relative to ATP, showing the
stability of the SRX in blebbistatin.
1640 Wilson et al.slow-twitch fibers. There was a fast decay, 54% of the
initial intensity, similar to that observed in the absence of
blebbistatin, that was assumed to come from nonspecific
probes and any myosin heads in the DRX (not complexed
with blebbistatin). A small component, 5% of the initial
fluorescence, decayed with a time constant of 252 s, similar
to the decay in the SRX in the absence of blebbistatin.
The most dramatic difference from the control fiber is the
appearance of a large component of the fluorescence inten-
sity, ~40% of the initial signal, that decayed with a time
constant too slow to be accurately measured with this pro-
tocol, R60 min (see Fig. 1 A and Table 1). Because bleb-
bistatin is highly specific for the myosin molecule, we
can conclude that the nucleotides with a very slow time
constant are bound to myosin-blebbistatin complex. Bleb-
bistatin shows a low fluorescence signal, more than an order
of magnitude less than that from the mant-nucleotides. This
signal remains constant during the experiment and thus
does not influence the results.
The effect of blebbistatin on nucleotide turnover in the
fibers depends on the fiber type. As described above for
slow-twitch muscle fibers, blebbistatin produces a large in-
hibition in the rate of nucleotide release by myosin in the
SRX but does not significantly increase the fraction of
probes released slowly. In fast-twitch muscle fibers in the
presence of blebbistatin, the rate of nucleotide release was
slightly faster but still inhibited, with little change in the
population of probes released slowly (Fig. 1 B). This agrees
well with small-angle x-ray diffraction findings by Xu et al.
(17) of a modest effect of blebbistatin on the affinity of
myosin heads for the core of the thick filament at 25C.
The effect of blebbistatin on the thick-filament structure in
slow-twitch muscle fibers has not been investigated using
x-ray diffraction or cryo-electron microscopy.
In the experiments described above, the chase solution
contains ATP and the fiber remains relaxed during the chase
phase. In the presence of ADP, myosin heads that are not in
the SRX bind tightly to actin and the fiber is no longer
relaxed. If the chase solution contains ADP, all nucleotides
are released quickly and the slow release of the nucleotides
in the SRX is not observed (21). We hypothesized that theBiophysical Journal 107(7) 1637–1646tight bond between some myosin heads and actin coopera-
tively destabilizes nearby myosin heads that are in the
SRX, disordering them and allowing them to also bind
rapidly to actin and release nucleotides. When fast- and
slow-twitch muscle fibers in the presence of blebbistatin
were chased with solutions containing ADP, release of nu-
cleotides was only very slightly increased, as shown in
Fig. 2.
The strong stabilization of the SRX by blebbistatin in
both slow and fast fibers under conditions where it is nor-
mally destabilized could arise due to the inhibition of the
strong bonds between actin and myosin by blebbistatin.
We previously hypothesized that such strong bonds are
required to destabilize myosin heads in the SRX (21).
Another possibility is that blebbistatin could provide such
a great degree of stability to the SRX that the formation
of strong actomyosin bonds can no longer have a significant
effect on it. Reducing blebbistatin concentration from 40 to
20 mM reduces the fraction of myosin heads bound to bleb-
bistatin, thus reducing force inhibition, from 90% to half
that amount (42). The larger fraction of myosin heads bind-
ing strongly to actin is demonstrated by the observation
that fibers shorten under these conditions, requiring immo-
bilization with steel pins to carry out the experiment. As
shown in Fig. 2, the myosin found in the long-lived
SRX at lower blebbistatin concentrations also remains rela-
tively unchanged during a chase with ADP. These results
show that blebbistatin provides such a high degree of
stability to the SRX that strong actomyosin bonds cannot
destabilize it.
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the SRX using spin-labeled nucleotides
The acquisition of EPR spectra of muscle fibers with a good
signal/noise ratio typically involves scanning for 10 min or
more. This constraint precludes obtaining spectra of spin-
labeled nucleotides in the SRX in fast and slow skeletal fi-
bers, where the lifetime of bound nucleotides is of the order
of 2–4 min. However, for tarantula muscle fibers (25) and
skeletal fibers in the presence of blebbistatin, the lifetime
is far greater, allowing spectral acquisition.
A large number of small bundles of fewer than six fibers
were dissected and aligned on the flat cell. The diameter of
the bundles needed to be small to provide adequate perfu-
sion for the SLATP, which is in low concentration and
cannot be replenished using standard recirculating systems.
Fibers were incubated first in rigor and then in relaxing so-
lution containing spin-labeled nucleotides in the presence
of blebbistatin (Methods). The fibers were then mounted
in a flat cell in which they could be oriented either parallel
or perpendicular to the magnetic field. Spectra were ob-
tained and the fibers were then removed from the cell and
washed in a relaxing solution containing 4 mM ATP plus
blebbistatin to remove any spin-labeled nucleotides not
bound at the active site with an extended lifetime. Fig. 3 AA
FIGURE 3 (A) EPR spectra of the spin-labeled analog of ATP, 2030SLATP, b
derivative of the absorption is shown as a function of the magnetic field. Th
(blue) or perpendicular to the magnetic field (red), showing a strong dependen
of the spectrum arise from free nucleotides; the broader peaks at high (P5) and lo
entirely to myosin. (B) EPR spectra are shown for slow-twitch muscle fibers align
tarantula fibers in the absence of blebbistatin (red). The spectra show that the or
and conditions. The spectra from the two muscle types were likewise similar whe
is 349.1 mT for parallel spectra and 350.0 mT for perpendicular spectra. All spect
nucleotide. To see this figure in color, go online.shows the strong effect of orientation on the EPR spectrum
of spin-labeled nucleotides bound to slow-twitch muscle fi-
bers in the presence of blebbistatin during this chase phase.
Each nitroxide spin probe contains one unpaired electron,
which gives rise to a three-line EPR spectrum in the pres-
ence of a strong magnetic field. If the probes are oriented
with respect to the magnetic field (i.e., the long axis of
the fiber), the splitting of these three lines is a function
of the angle between the principal axis of the spin probe
and the magnetic field. If this angle is large, the splitting
is small. The three sharp peaks (P2–P4) in the center of
the blue spectrum in Fig. 3 A arise from residual free nucle-
otides. Their sharpness is due to motional narrowing of
the lines. These fibers had been washed with a relaxing so-
lution for >5 min, which removes most but not all of the
free nucleotides. In addition, some nucleotides are released
from myosin during the acquisition of the spectra, adding to
the free population. The broad peaks seen at both high (P5)
and low magnetic field (P1) arise from nucleotides that are
immobilized by binding to proteins, primarily myosin. Both
bound and free probes contribute to the central peak, P3,
which can be seen as a two-peak superposition in the red
spectrum in Fig. 3 A. The red spectrum shows the same fi-
bers aligned with the fiber axis perpendicular to the mag-
netic field. Due to the stagger of the myosin heads aroundB
ound to slow-twitch muscle fibers in the presence of blebbistatin. The first
e fibers were oriented with their long axis parallel to the magnetic field
ce on the orientation. The three sharp peaks (P2–P4) in the central region
w field (P1) arise from nucleotides bound to specific sites in the fiber, almost
ed parallel to the magnetic field in the presence of blebbistatin (blue) and for
ientation of the spin-labeled nucleotides is very similar for these two fibers
n the fibers were aligned perpendicular to the magnetic field. The center field
ra are 10 mTwide. Spectra were aligned on the central (P3) peak of unbound
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1642 Wilson et al.the thick filament as they project out azimuthally from the
thick filament, this spectrum approximates randomly ori-
ented EPR probes. As can be seen, the blue (parallel) and
red (perpendicular) spectra are quite different in the high-
field (P5) and low-field (P1) regions, indicating that the
spin probe bound to myosin is oriented on the myosin mole-
cule. As also can be seen (Fig. 3 A, blue), when fibers are
oriented parallel to the magnetic field the splitting between
high-field and low-field peaks is large, showing that the
angle between probes and the magnetic field is small with
probes aligned primarily along the long axis of the fiber
(see Discussion).
Questions concerning the SRX include whether its struc-
ture is similar in different fiber types and whether the state
stabilized by blebbistatin is similar to the SRX in its
absence. Fig. 3 B compares the spectra obtained from
slow-twitch vertebrate muscle fibers in the presence of
blebbistatin with that of tarantula exoskeletal fibers
without blebbistatin, with both preparations aligned paral-
lel to the magnetic field. These two spectra are very
similar. As expected, they are also similar when the fibers
are aligned perpendicular to the magnetic field (not
shown). The almost identical nature of the spectra from
different muscles suggests that the orientation of bound
nucleotides in the two very diverse fiber types is similar
and that the state stabilized by blebbistatin is similar to
that in its absence.A B
FIGURE 4 (A) The release of spin-labeled nucleotides from slow-twitch
fibers and from myosin is shown as a function of time during a chase with
unlabeled ATP. Data obtained from fibers are shown in the presence (solid
circles) and absence (open squares) of blebbistatin. Solid diamonds repre-
sent data obtained from myosin isolated from slow-twitch fibers in the
presence of blebbistatin. In the presence of blebbistatin, the release of nu-
cleotides from fibers is slow, with a time constant similar to that seen with
fluorescent nucleotides. A fraction of the probes, 40%, is released fairly
quickly, with a time constant of 14 min. Another faction, 31%, is released
more slowly, with a time constant of 88 min, and the remaining probes,
29%, are released even more slowly (too slowly to be measured in this
assay). In the absence of blebbistatin, all nucleotides are released from
the fibers before the first time point at 3 min. The major fraction of nucle-
otides, 83%, is released from myosin plus blebbistatin with a time constant
of 16 min. (B) Release of spin-labeled nucleotides from fast-twitch fibers
(solid circles) and from purified myosin (open circles), both in the presence
of blebbistatin. Fits to the data show a single-exponential decay with a time
constant of 10.6 min for myosin and a two-phase decay for fibers with a
slow phase representing 66% of the initial intensity and with a time constant
of 31 min.The kinetics of nucleotide release measured
using spin-labeled nucleotides
The release of spin-labeled nucleotides from the fiber can
be monitored in a pulse-chase experiment similar to that
performed with the fluorescent nucleotides. Slow-twitch
muscle fibers were incubated with spin-labeled nucleotides
in the presence of blebbistatin. An aliquot of concentrated
ATP was added to the fibers to bring the concentration to
4 mMATP. The release of bound nucleotides could be moni-
tored either from the decrease in the height of the low-field
peak arising from the bound nucleotides or from the in-
crease in the height of the sharp peak arising from free
nucleotides.
The change in amplitude of the peak arising from free
nucleotides provides a good measure of the release of
bound nucleotides, because in this experimental protocol,
no nucleotides leave the volume observed after their
release. Due to the nature of the EPR spectrum, a given
height of the different peaks represents different popula-
tions of probes contributing to that peak. For example, a
given height for one of the bound peaks (P1 or P5) rep-
resents many more spins than does equal height of the
peaks arising from the free nucleotides (P2–P4). The
exact proportion allotted to each peak can be determined
by plotting the intensity of the peak arising from bound
probes versus that arising from free nucleotides in eachBiophysical Journal 107(7) 1637–1646experiment. The slope of this plot, which is a straight
line, shows that the bound-peak height represents 23 5
3 times the number of spins for the same height of a
free peak.
Fig. 4 shows the release of bound spin-labeled nucleo-
tides in the presence of blebbistatin from slow-twitch puri-
fied myosin (diamonds) and fibers (circles) as a function of
time. The myosin samples were in the same buffer used
in the fiber experiments, which has an ionic strength such
that the myosin has formed synthetic thick filaments. The
nucleotide lifetime in slow synthetic thick filaments was
480 s, faster than the three phases found in slow fibers;
45% of the initial signal was released in a more rapid phase
with a time constant of ~900 s, 20% with a time constant of
2400 s, and 35% with a much slower time constant that was
too long to be measured. The slower phases are similar to
those observed for the fluorescent nucleotides, as shown in
Fig. 1 and Table 1. In the absence of blebbistatin, all nucle-
otides were released rapidly within the time required to
add competing ATP and obtain the first spectrum, ~2 min
(Fig. 4 A, squares). Fig. 4 B contrasts the release of spin-
labeled nucleotides from fast-twitch myosin and fibers in
the presence of blebbistatin, corresponding to lifetimes of
900 and 2000 s, respectively. The release of nucleotides
from fast fibers is faster than that from slow fibers, a result
also seen with fluorescent nucleotides (see Table 1 and
Blebbistatin Stabilizes the Super-Relaxed State 1643Fig. 1). The rate of nucleotide release was the same for syn-
thetic myosin thick filaments and for myosin subfragment
1. The release was also similar in the standard buffer of
ionic strength 250 mM to that observed in buffer of higher
ionic strength, 500 mM. The high degree of inhibition of
purified myosin by blebbistatin could be due to stabiliza-
tion of the IHM in the myosin molecules, an effect
observed in electron microscopy (2). However, the last
two observations rule this possibility out, as the IHM
cannot be formed by subfragment 1, nor can it be formed
in high ionic strength.
Monitoring the conformation of the nucleotide-binding pocket
in the SRX
One unanswered question concerning the SRX is how the
inhibition of ATP turnover is achieved. Is the nucleotide
pocket in an unusual conformation, more closed or more
open? Previous work in our lab has shown that one can
monitor the conformation of the nucleotide pocket using
the mobility of spin probes (SLADP) attached to nucleotides
that are bound specifically to myosin (30,32). The spin
probe undergoes subnanosecond rotational motion that is
constrained by the adjoining protein surface. The greater
the constraint provided by the protein surface, the less the
mobility of the probe, leading to a greater splitting between
the low-field peak (P1) and the high-field dip (P5) in the
spectra. Baseline probe mobility is obtained from the spec-
trum of randomly oriented minced samples. We found the
low-field to high-field splitting to be 6.6 mT for SLADP
bound to randomly oriented slow-twitch skeletal muscle fi-
bers in the presence of blebbistatin; 6.6 mT for randomly
oriented tarantula fibers; and 6.5 mT for fast muscle myosin.
From the similarity of the spectra, we conclude that there is
not a dramatic change in the conformation of the nucleotide
pocket of myosin in the SRX.DISCUSSION
Nucleotide release in the presence and absence
of blebbistatin
Nucleotide turnover times for myosin from relaxed fast-
and slow-twitch fibers are ~16 and 25 s, respectively
(40,41). In the SRX, nucleotide turnover time increases
by a factor of 15 in fast-twitch muscle fibers, from 16 s
to 250 s, and by a factor of 6 in slow-twitch muscle fibers,
from 25 s to 150 s (21,22) (see Table 1). Blebbistatin is a
small molecule that inhibits the ATPase activity of a variety
of myosin 2 isoforms, and as such would be expected
to inhibit the ATPase activity of myosin in relaxed fibers
(13,15,16). Addition of blebbistatin to resting fibers has a
strong effect on nucleotide turnover times observed in
both fast- and slow-twitch muscle fibers, extending the turn-
over time from 150–250 s to 30 min or greater. There was a
small increase, ~5%, in the population of myosin in theSRX in slow-twitch fibers. As can be seen in Fig. 1 B, the
release of nucleotides in both fiber types is very slow, but
it is slower in slow-twitch fibers than in fast-twitch fibers.
In fast fibers there is a population of probes that is released
with an ~1 h turnover time, whereas in slow-twitch fibers
release is even slower and beyond the ability of the current
assay to measure. A faster release of nucleotides in fast-
twitch fibers is also seen in the release of spin-labeled nu-
cleotides (Fig. 4). Although the rates of nucleotide release
are similar for spin and fluorescent nucleotides, they are
not identical due to different protocols, e.g., bundles of fi-
bers in an EPR cell versus single fibers surrounded by solu-
tion, and possibly due also to the use of different probes. It
has been shown previously that myosin regulatory light
chain phosphorylation produces a modest reduction in the
stability of the SRX (22). Due to the large degree of stabil-
ity conferred by blebbistatin, phosphorylation would be ex-
pected to have little effect in its presence, but this was not
checked here.
Blebbistatin could inhibit nucleotide turnover in muscle
fibers by stabilizing the SRX or by simply inhibiting myosin
ATP turnover. In the presence of blebbistatin, the time
constants for nucleotide release from purified myosin
thick filaments are a little slower than those measured previ-
ously using steady-state ATPase assays for purified myosins
and myosin subfragment 1 (13,15,16). The release rates
observed for purified myosin are much faster than those
observed in the slow phase for either fast- or slow-twitch fi-
bers in the presence of blebbistatin. These observations sug-
gest that the very slow nucleotide turnover times observed in
the muscle fibers are due to stabilization of the SRX by bleb-
bistatin. This stability allowed us to measure orientations
and conformations of myosin heads in the SRX, since sig-
nals from free nucleotides or nonspecifically bound nucleo-
tides were easily washed out, with little loss of spin-labeled
nucleotides bound to myosin during the chase phase.Correlation between the SRX and structural
studies
Our previous work on the SRX has shown that there is a cor-
relation between the lifetime of the SRX and the stability of
the IHM (22). As blebbistatin has been shown by electron
microscopy and x-ray diffraction to stabilize the IHM
(11,17,18), it would be expected to extend nucleotide turn-
over times in fibers. Our basic observation shows that this
is true and again supports the previously proposed cor-
relation between structure and nucleotide turnover in the
SRX. The small increase in the population of the SRX
observed here correlates well with the lack of change in
the stability of myosin heads in the thick filament array
observed by x-ray diffraction at 25C (17). The effect of
blebbistatin on thick filament structure in skeletal muscle fi-
bers has not been measured by cryo-electron microscopy.
Thus, we conclude that there is a reasonable correlationBiophysical Journal 107(7) 1637–1646
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functional studies of the SRX and the stability of the array of
myosin heads bound to the core of the thick filament
observed by cryo-electron microscopy or x-ray diffraction.
Previous work in our laboratory showed that in fast skel-
etal muscle, a chase with either ADP or an activating solu-
tion resulted in rapid release of all nucleotides bound to the
fiber (20,21). A similar result was also obtained for slow
skeletal fibers. We hypothesized that the binding of myosin
to actin synergistically and cooperatively destabilized
myosin heads in the SRX, and that this cooperative destabi-
lization was necessary to achieve a very rapid, full acti-
vation of muscle fibers. However, in the presence of
blebbistatin, a chase with ADP had little effect on the
release of nucleotides from myosin heads in the SRX (see
Fig. 2). As blebbistatin prevents myosin heads from attach-
ing strongly to actin, this observation could be due to bleb-
bistatin’s prevention of the formation of such bonds, or to
blebbistatin stabilizing the SRX to such an extent that strong
bond formation no longer affects it. By conducting the
experiment at lower levels of blebbistatin, where a chase
with ADP will result in strong bond formation, we show
that the latter explanation accounts for the data. The great
stability of the SRX observed here for fibers in the presence
of ADP correlates well with the observation that blebbista-
tin stabilizes the IHM in ADP, as observed by cryo-electron
microscopy (18). Interestingly, skeletal fibers in the pres-
ence of blebbistatin resemble cardiac fibers in the absence
of blebbistatin in that in both cases, strong bonds between
actin and myosin do not affect the SRX (21). Observations
of probe orientation, discussed below, also provide support
for the conclusion that blebbistatin stabilizes the IHM in
skeletal fibers.Probe orientation in the SRX
Studies of relaxed muscle fibers using spin-labeled nucleo-
tides have been hampered by the fact that these nucleotide
analogs do not function with standard ATP-regeneration
systems such as creatine kinase, and that the signal from
high concentrations of free nucleotides swamps out the
signal from the bound nucleotides. To avoid these problems,
previous studies of the relaxed state using spin-labeled
nucleotides have used the phosphate analogs AlFx, BeFx,
or Vi to stabilize a relaxed state. Although all of these ana-
logs produced a mechanically relaxed fiber, the spectra from
these states showed completely disordered spin probes (30–
32). Although these ligands have been shown by x-ray
diffraction to stabilize the binding of myosin to the thick
filament in rabbit psoas, they were much less effective
than blebbistatin (3,17). They also stabilized thick filament
structure of negatively stained tarantula filaments (19).
Here, we used blebbistatin to stabilize nucleotides in the
SRX in skeletal muscle fibers. The spectra show a clear indi-
cation of oriented probes. This is to our knowledge the firstBiophysical Journal 107(7) 1637–1646observation of oriented EPR probes on the myosin motor
domain in relaxed skeletal muscle fibers. Similar spectra
were also obtained from tarantula fibers, suggesting that
the order seen is intrinsic to the IHM. Thus, we conclude
that the IHM is stabilized more effectively by blebbistatin
than by phosphate analogs in vertebrate skeletal fibers, in
agreement with previous x-ray diffraction studies.
The orientation of the probes shown in Fig. 3 can be
determined by comparison with simulations produced by
solving the spin Hamiltonian for different probe configura-
tions. Barnett and co-workers simulated spectra for distribu-
tions of probes that have a different mean orientation to the
magnetic field,Qo, and Gaussian distributions with different
full widths at half-maximum, Dq, about this mean (43). The
spectra shown in Fig. 3 are similar to the simulation of a
distribution of probes oriented along the fiber axis with
Qo ¼ 0, having a Gaussian distribution of full width
Dq ¼ 90 about this mean. The breadth of the distribution
of the probes may arise from the disorder of the probes rela-
tive to the myosin heads and from the two different orienta-
tions of the nucleotide sites in the IHM.The conformation of the nucleotide pocket in the
SRX is similar to that in Myosin,ADP
The EPR spectrum of randomly oriented samples provides
information on the rotational mobility of the probes. This
in turn provides information on the conformation of the pro-
tein surface in the vicinity of the bound probe, in this case,
the protein surface in the vicinity of the nucleotide pocket
of myosin. There is little change between the spectrum
of SLADP bound to myosin and the spectrum of SLADP
bound to slow fibers in the presence of blebbistatin during
the chase phase. Previous work has shown that the spectrum
of SLADP bound to myosin is virtually unchanged between
fast myosin and slow myosin and is unchanged upon addi-
tion of phosphate analogs AlFx, BeFx, and Vi (31).
Together these data suggest that there has been no signifi-
cant rearrangement of the conformation of the myosin
nucleotide pocket in the SRX as measured by spin probes
bound to the ribose of the nucleotide. The magnitude of
the low-field to high-field splitting can be modeled as the
motion of the probe in a cone of revolution, with larger
splitting indicating a smaller vertex cone angle (44). The
protein surface is most certainly not a cone of revolution,
but the analysis serves as an approximation to correlate
changes in the magnetic field with a change in the restrictive
nature of the protein surface. The splitting observed here,
which is equivalent to that previously observed for fast
myosin, corresponds to a cone angle of ~60, which implies
a closed nucleotide site (31). Previous work using cryo-
electron microscopy has also suggested that the switch
regions of myosin at the nucleotide site are in a closed
conformation in the SRX (19). These observations suggest
that the inhibition of myosin’s ATPase activity seen in the
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otide pocket. Inhibition could be the result of immobiliza-
tion of the myosin head, which has been observed in
previous studies (45–47).Significance
The SRXmay play an important role in whole-body thermo-
genesis and thus in human health. Human movement is a
contributor to caloric expenditure and metabolic rate. Thus,
the increasingly sedentary lifestyle in modern human culture
may be a major contributor to the public rise in obesity and
related diseases. Studies have indicated that low-intensity
movement, such as walking periodically throughout the
day, can account for as much as 300 Cal, and that for some
people, this might be enough to prevent obesity (48). In
addition, if regular movement throughout the day prevents
muscle from spending as much time in the SRX, muscle,
and therefore whole-body metabolic rate, would be higher
when not moving, i.e., when relaxed but not super-relaxed.
Another unanswered question concerns the kinetics for
transitions into and out of the SRX, which, although they
have not been measured, are presumed to be fast.
It is not known how frequently movement must occur to
avoid the SRX, and the SRX in human muscle fibers has
not yet been verified. However, it is found in a broad range
within the evolutionary spectrum, and its caloric effects are
significant, e.g., helping species that spend significant time
lying in wait for prey (such as the tarantula) from dying of
starvation while they sit motionless for long periods of
time. Thus, avoiding the SRX might contribute as much to
caloric expenditure and metabolic rate as low-intensity reg-
ular movement itself.
Pharmaceuticals that would cause myosin heads to transi-
tion out of the SRX and into the DRX could raise metabolic
rate and prove effective for treating obesity and type 2 dia-
betes (20). The development of such pharmaceuticals re-
quires a better understanding of the properties of the SRX
and how to manipulate it. To reach this goal, one must first
develop an assay amenable to the high-throughput robotic
methods currently used to identify therapeutic molecules.
Conditions that stabilize the SRX would be useful in devel-
oping high-throughput assays, and blebbistatin is shown
here to stabilize the SRX. However, we further show that
blebbistatin provides such a high degree of stability to the
SRX that mechanisms known to destabilize the SRX are
not effective in its presence. Thus, blebbistatin provides a
useful tool to aid in the development of an assay. However,
screening in the presence of blebbistatin could miss poten-
tially useful compounds.CONCLUSION
Blebbistatin stabilizes the SRX, producing a very long-lived
myosin-nucleotide complex that facilitates structural andother studies. Using blebbistatin, we show that spin probes
bound to the myosin nucleotide site are oriented, and that
the conformation of the nucleotide site has not changed.
Blebbistatin has been shown in other structural studies to
stabilize the IHM (11,18). Thus, the results presented here
strengthen the conclusion that the myosin heads in the
SRX are also in the IHM. Our observation of the very
long life of the SRX in slow-twitch fibers in the presence
of blebbistatin suggests that this would make a good model
system for further structural studies of this motif in a skel-
etal muscle.
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